Thomas Sun

Learn More
Triple-negative breast cancer (TNBC) represents an aggressive subtype, for which radiation and chemotherapy are the only options. Here we describe the identification of disulfiram, an FDA-approved drug used to treat alcoholism, as well as the related compound thiram, as the most potent growth inhibitors following high-throughput screens of 3185 compounds(More)
  • Tyler J. W. Robinson, Jeff C. Liu, Frederick Vizeacoumar, Thomas Sun, Neil Maclean, Sean E. Egan +3 others
  • 2013
Triple negative breast cancer (TNBC) includes basal-like and claudin-low subtypes for which only chemotherapy and radiation therapy are currently available. The retinoblastoma (RB1) tumor suppressor is frequently lost in human TNBC. Knockdown of RB1 in luminal BC cells was shown to affect response to endocrine, radiation and several antineoplastic drugs.(More)
—This paper reports on the development of a flexible 5-MBd equalized M-QAM testbed for high-speed wireless data communications. The unit operates in real time and was field tested in typical indoor environments. A total of 3600 independent experiments were conducted using the testbed where one of 4-, 16-, 64-QAM constellations were transmitted, and the(More)
  • 1